TScan Therapeutics, Inc. (TCRX)
NASDAQ: TCRX · Real-Time Price · USD
1.890
+0.020 (1.07%)
Sep 4, 2025, 4:00 PM - Market closed
TScan Therapeutics Market Cap
TScan Therapeutics has a market cap or net worth of $107.25 million as of September 4, 2025. Its market cap has decreased by -64.73% in one year.
Market Cap
107.25M
Enterprise Value
-14.09M
1-Year Change
-64.73%
Ranking
Category
Stock Price
$1.89
Market Cap Chart
Since the IPO on July 16, 2021, TScan Therapeutics's market cap has decreased from $359.08M to $107.25M, a decrease of -70.13%. That is a compound annual growth rate of -25.33%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 3, 2025 | 106.12M | -38.22% |
| Dec 31, 2024 | 171.78M | -38.39% |
| Dec 29, 2023 | 278.82M | 647.03% |
| Dec 30, 2022 | 37.32M | -65.09% |
| Dec 31, 2021 | 106.93M | -70.22% |
| Jul 16, 2021 | 359.08M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 660.01B |
| Johnson & Johnson | 428.83B |
| AbbVie | 374.37B |
| UnitedHealth Group | 279.67B |
| Novo Nordisk | 248.91B |
| AstraZeneca | 247.16B |
| Novartis AG | 245.38B |
| Abbott Laboratories | 228.80B |